title: Dopamine Use in Intensive Care: Are We Ready to Turn it Down?
abstract: Dopamine is still frequently used as a first line vasopressor agent in hypotensive patients, when physicians are afraid of noradrenaline and believe that dopamine, with its β and α, inotrope and vasopressor effects, may be helpful. Evidence exists that it does not offer protection from renal failure, even if at low doses (0, 3-5 mcg/Kg/min) it may exert its effects on D1 and D2 receptors resulting in natriuresis and renal vasodilation, augmentation in renal blood flow, and diuresis. The effects of dopamine on gastrointestinal system and splanchnic perfusion in critical care patients are even more controversial, since they seem to be at least partially dependent on the initial fractional splanchnic blood flow. Dopamine may exert deleterious effects on respiratory function, by impairing the ventilatory drive response to hypoxemia and hypercapnia and reducing arterial oxygen saturation through a regional ventilation/perfusion mismatching. Dopamine seems to affect the cellular mediated mechanism of the immune function directly by its action on receptors located on immune system cells and indirectly altering the hormonal response regulating immune response. In this paper, the use of low dose dopamine is discussed in the intensive care perspective.
authors.affiliation: Dipartimento di Scienze Chirurgiche Anestesiologiche e dell'Emergenza "G. Zannini", Università degli Studi di Napoli "Federico II", Naples, Italy.
authors.forename: Geremia Zito
authors.initials: GZ
authors.lastname: Marinosci
authors.forename: Edoardo
authors.initials: E
authors.lastname: De Robertis
authors.forename: Giuseppe
authors.initials: G
authors.lastname: De Benedictis
authors.forename: Ornella
authors.initials: O
authors.lastname: Piazza
keywords: ICU; dopamine; shock; vasopressor
references.citation: Minerva Anestesiol. 2007 Sep;73(9):447-50
references.pmid: 17660736
references.citation: Lancet. 2000 Dec 23-30;356(9248):2139-43
references.pmid: 11191541
references.citation: Am J Physiol. 1988 Oct;255(4 Pt 2):F666-73
references.pmid: 2845809
references.citation: Chest. 1995 Dec;108(6):1648-54
references.pmid: 7497776
references.citation: J Med Case Rep. 2011 Oct 21;5:520
references.pmid: 22018019
references.citation: Shock. 2010 Feb;33(2):225; author reply 225-6
references.pmid: 20081496
references.citation: Eur J Cardiothorac Surg. 1999 May;15(5):717-21; discussion 721-2
references.pmid: 10386423
references.citation: Crit Care Med. 1993 Sep;21(9):1296-303
references.pmid: 8370292
references.citation: Minerva Anestesiol. 2011 Jan;77(1):96
references.pmid: 21273970
references.citation: Circ Res. 1965 Jun;16:510-7
references.pmid: 14299503
references.citation: Neurochem Res. 2009 Jul;34(7):1289-92
references.pmid: 19132530
references.citation: Int J Gen Med. 2010 Oct 05;3:287-95
references.pmid: 21042567
references.citation: Transl Med UniSa. 2012 Apr 30;3:1-14
references.pmid: 23905047
references.citation: Am J Med. 1996 Jul;101(1):49-53
references.pmid: 8686714
references.citation: Kidney Int. 1984 Oct;26(4):375-83
references.pmid: 6396435
references.citation: J Mol Endocrinol. 1995 Apr;14(2):139-55
references.pmid: 7619204
references.citation: Shock. 2004 Mar;21(3):261-70
references.pmid: 14770040
references.citation: N Engl J Med. 1963 Nov 14;269:1060-4
references.pmid: 14085064
references.citation: Crit Care Med. 1994 Dec;22(12):1919-25
references.pmid: 7988127
references.citation: Intensive Care Med. 2000 Jul;26(7):901-7
references.pmid: 10990104
references.citation: Anesthesiology. 2004 May;100(5):1188-97
references.pmid: 15114217
references.citation: Arch Int Physiol Biochim. 1984 Nov;92(4):S11-20
references.pmid: 6085236
references.citation: Intensive Care Med. 1997 Jan;23(1):31-7
references.pmid: 9037637
references.citation: Intensive Care Med. 2002 Jul;28(7):877-83
references.pmid: 12122525
references.citation: Clin Transplant. 2012 Nov-Dec;26(6):E571-5
references.pmid: 23121213
references.citation: Crit Care Med. 2012 Jan;40(1):354; author reply 354-5
references.pmid: 22179381
references.citation: Crit Care Med. 2006 Mar;34(3):589-97
references.pmid: 16505643
references.citation: New Microbiol. 2012 Apr;35(2):199-206
references.pmid: 22707133
references.citation: Am J Respir Cell Mol Biol. 2005 Nov;33(5):432-7
references.pmid: 16234332
references.citation: Crit Care Med. 1994 Jan;22(1):61-8
references.pmid: 8124976
references.citation: Shock. 2001 Jan;15(1):1-10
references.pmid: 11198350
references.citation: Clin Sci (Lond). 1993 Apr;84(4):357-75
references.pmid: 8482041
references.citation: Crit Care Med. 2001 Aug;29(8):1526-31
references.pmid: 11505120
references.citation: J Clin Invest. 1964 Jun;43:1116-24
references.pmid: 14171789
references.citation: Med Sci Monit. 2006 Feb;12(2):CR90-3
references.pmid: 16449954
references.citation: Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):425-33
references.pmid: 22697074
references.citation: Intensive Care Med. 2010 Sep;36(9):1612-3
references.pmid: 20397004
references.citation: Acta Anaesthesiol Scand. 2010 Feb;54(2):183-90
references.pmid: 19764906
references.citation: New Horiz. 1995 Nov;3(4):597-607
references.pmid: 8574590
references.citation: Clin Endocrinol (Oxf). 1995 Oct;43(4):457-63
references.pmid: 7586621
references.citation: Panminerva Med. 2011 Sep;53(3):203-10
references.pmid: 21775947